Ian Hudson
Ian Robert Burton Hudson
Career
Hudson practised as a paediatrician from 1982 to 1989, and then worked in clinical
Hudson was also a member of the European Medicines Agency's management board, a member of the Heads of Medicines Agencies of Europe Management Group and chaired the International Coalition of Medicines Regulatory Authorities between 2016 and 2019. He retired from the MHRA in 2019 and then worked as a senior advisor, Integrated Development, Bill and Melinda Gates Foundation until retiring in February 2024. He was also the Chair of the International Review Panel for clinical trial accreditation, UKCRC Clinical Trials Unit Network, a member of the Centre for Innovation in Regulatory Science scientific advisory board, and a member of the scientific advisory council of TOPRA. [citation needed] He was appointed an OBE in the 2020 New Year Honours for services to healthcare.[3]
See also
- June Raine, CEO of the MHRA from 2019
References
- ^ "Chief Executive Dr Ian Hudson". gov.uk. UK Government. Retrieved 21 September 2018.
- ^ "Dr Ian Hudson appointed as the MHRA's new Chief Executive". gov.uk. UK Government. Retrieved 21 September 2018.
- ^ "No. 62866". The London Gazette (Supplement). 28 December 2019. p. N12.